Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction.

Abelin, Jennifer G; Harjanto, Dewi; Malloy, Matthew; Suri, Prerna; Colson, Tyler; Goulding, Scott P; Creech, Amanda L; Serrano, Lia R; Nasir, Gibran; Nasrullah, Yusuf; McGann, Christopher D; Velez, Diana; Ting, Ying S; Poran, Asaf; Rothenberg, Daniel A; Chhangawala, Sagar; Rubinsteyn, Alex; Hammerbacher, Jeff; Gaynor, Richard B; Fritsch, Edward F; Greshock, Joel; Oslund, Rob C; Barthelme, Dominik; Addona, Terri A; Arieta, Christina M; Rooney, Michael S

Abelin, Jennifer G; Harjanto, Dewi; Malloy, Matthew; Suri, Prerna; Colson, Tyler; Goulding, Scott P; Creech, Amanda L; Serrano, Lia R; Nasir, Gibran; Nasrullah, Yusuf; McGann, Christopher D; Velez, Diana; Ting, Ying S; Poran, Asaf; Rothenberg, Daniel A; Chhangawala, Sagar; Rubinsteyn, Alex; Hammerbacher, Jeff; Gaynor, Richard B; Fritsch, Edward F; Greshock, Joel; Oslund, Rob C; Barthelme, Dominik; Addona, Terri A; Arieta, Christina M; Rooney, Michael S.

Immunity ; 54(2): 388, 2021 Feb 09.

Article in En | MEDLINE | ID: mdl-33567264

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google